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Myoclonic epilepsies with onset in infancy and childhood are clinically and etiologically heterogeneous. Although
genetic factors are thought to play an important role, to date very little is known about the etiology of these
disorders. We ascertained a large Italian pedigree segregating a recessive idiopathic myoclonic epilepsy that starts
in early infancy as myoclonic seizures, febrile convulsions, and tonic-clonic seizures. We typed 304 microsatellite
markers spanning the 22 autosomes and mapped the locus on chromosome 16p13 by linkage analysis. A maximum
LOD score of 4.48 was obtained for marker D16S3027 at recombination fraction 0. Haplotype analysis placed
the critical region within a 3.4-cM interval between D16S3024 and D16S423. The present report constitutes the
first example of an idiopathic epilepsy that is inherited as an autosomal recessive trait.
Introduction
Myoclonic seizures are common features of many epi-
lepsies at all ages and often represent nonspecific epi-
leptic manifestations (Fejermann 1991). In the specific
subgroup of myoclonic epilepsies, however, myoclonic
seizures are invariably present and are the most prom-
inent symptom. Among these syndromes, the classifi-
cation of myoclonic epilepsies with onset in infancy and
childhood has been a source of controversy because
other types of seizures frequently accompany myoclonic
attacks and the cerebral origin and etiology of epileptic
discharges are uncertain. The International Classifica-
tion of Epilepsies and Epileptic Syndromes (ICE) (Com-
mission on Classification and Terminology of the Inter-
national League against Epilepsy 1989) recognizes
different myoclonic epilepsies with onset in the first year
of life. They include idiopathic benign myoclonic epi-
lepsy in infancy (BIME), the symptomatic early my-
oclonic encephalopathy, and severe myoclonic epilepsy
of infancy (SIME).
Familial myoclonic epilepsies of infancy have rarely
been described (Fujiwara et al. 1990; Dravet et al.
1992a), although an increased incidence of idiopathic
epilepsy or febrile convulsions in relatives of probands
has been frequently described (Dalla Bernardina et al.
1982; Dravet et al. 1992b; Lin 1998). The sporadic
Received January 14, 2000; accepted for publication February 28,
2000; electronically published March 30, 2000.
Address for correspondence and reprints: Dr. Federico Zara, La-
boratorio di Genetica Umana, E.O. Ospedali Galliera, Via Volta 10r,
16128, Genoa, Italy. E-mail: f.zara@galliera.it
q 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6605-0010$02.00
nature of these myoclonic disorders has further com-
plicated their classification into syndromic entities, and,
therefore, many cases of infantile myoclonic epilepsy
remain unclassified (Jeavons 1977; Aicardi 1986).
To date, very little is known about the etiology of
idiopathic myoclonic epilepsies, although genetic fac-
tors are thought to play an important role (Minassian
et al. 1995). Two loci predisposing to juvenile myoclonic
epilepsy (MIM 254770) have been mapped to chro-
mosome 6p and 15q (Liu et al. 1995; Elmslie et al.
1997), and a locus for an adult form of benign familial
myoclonic epilepsy (MIM 601068) has been mapped to
chromosome 8q24 in Japanese families (Mikami et al.
1999; Plaster et al. 1999).
To date, no data are available on genetic factors in-
volved in myoclonic epilepsy of infancy. We ascertained
a large Italian pedigree segregating an autosomal re-
cessive idiopathic myoclonic epilepsy that starts in early
infancy, characterized by very frequent and often long-
lasting myoclonic seizures, febrile convulsions, and gen-
eralized tonic-clonic seizures (GTCS). In this article, we
report the genetic mapping of an autosomal recessive
locus for idiopathic myoclonic epilepsy of infancy to
chromosome 16p13.
Subjects and Methods
Case Report
Two related branches (fig. 1) make up the Italian fam-
ily. The founders of generation I were not consanguin-
eous, despite origin from the same geographic area (Na-
ples), and were not reported to be affected. The four
individuals (two sib pairs) of generation II did not show
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Figure 1 Pedigree and chromosome 16p13 haplotypes of the Italian family segregating idiopathic myoclonic epilepsy of infancy. Filled
symbols, affected subjects; unfilled symbols, individuals with no history of seizures. Individuals IV-6 and IV-22 had GTCSs and febrile convulsion,
respectively. Individuals III-8, III-13 and III-14 did not consented to the study. Arrows, key recombinations that define the critical region.
any clinical symptoms of the disease or any epilepsy-
related episodes. Electroencephalograms (EEGs; re-
corded at mean age 60 years) were normal for individ-
uals II-1, II-3, and II-4 but not for individual II-2, who
showed mild localized paroxysmal abnormalities over
the temporal regions. Of 14 individuals of generation
III, 11 consented to the study, and 7 of them are affected.
Clinical features of myoclonic epilepsy may be sum-
marized as follows: onset at 4–8 mo of age with GTCS
in subjects III-2, III-3, III-4, and III-5; appearance of
myoclonic seizures at age 5–36 mo and persistence to
adulthood in all patients; febrile convulsions at age 5
mo to 3 years in individuals III-2, III-3, III-4, III-5, and
III-6; very frequent myoclonic seizures (several times a
day) in childhood, lasting for many hours, sometimes
preceding a convulsive seizure, spontaneous or induced
by fatigue or drowsiness, acoustic stimuli or variations
in light intensity, the intense “green” color, repetitive
movements of the hands; GTCS in all affected individ-
uals, more frequent in childhood and adolescence, spo-
radic or absent in adult age; interictal EEGs normal or
with mild abnormalities; ictal EEGs showing bisyn-
chronous spike waves; cranial computed topography
scan and magnetic resonance imaging (MRI) negative
for any detectable brain lesions; and good control of
both myoclonic and GTCSs with Valproate.
The fourth generation accounts for 30 individuals.
Twenty are the offspring of affected individuals, and
none shows any symptom of the disease. Individual IV-
4, however, showed an idiopathic generalized epilepsy
that started at age 19 years (two GTCSs, with normal
MRI), and individual IV-16 had febrile convulsions at
age 5 years.
DNA Samples and Genotyping
Ten milliliters of peripheral blood were obtained from
consenting individuals and were used for DNA extrac-
tion. Microsatellite markers were selected from the Ge´-
ne´thon map (Dib et al. 1996). Markers were typed by
following two different procedures: (a) PCR amplifica-
tions were performed by use of g-[32P]-dATP end-labeled
forward primers and then separated onto 6% denatur-
ating gel that was subsequently vacuumed and exposed
to autoradiography; and (b) sets of 10–12 PCR ampli-
fications were electrophoresed on 6% denaturating gels
that were subsequently blotted on nylon membranes.
Filters were hybridized with multiple sets of two to three
radiolabeled primers that specifically recognize nonov-
erlapping amplifications and that were then exposed to
autoradiography (Tournier-Lasserve et al. 1993).
PCR amplifications were carried out as described by
Gennaro et al. (1999) with 35 cycles of 947C for 40 s
and 557C for 30 s. In a few selected cases, a specific
annealing temperature was used.
Linkage Analysis
Two-point and multipoint linkage analysis was per-
formed by respective use of the MLINK and LINKMAP
1554 Am. J. Hum. Genet. 66:1552–1557, 2000
Figure 2 Genetic map of chromosome 16p13 markers. Order
of markers and distances are taken from the Ge´ne´thon map. Markers
harboring the critical region are indicated in bold.
Table 1
Two-Point LOD Scores for Chromosome 16p13 Markers
LOCUS
LOD AT v
0 .05 .2 .3 .4 .1
D16S521 2` 1.70 1.74 1.45 .94 .34
D16S3024 2` 1.50 1.72 1.52 1.01 .37
D16S3082 1.81 1.61 1.41 .99 .58 .20
D16S3084 2.94 2.61 2.27 1.59 .93 .32
D16S3027 4.48 4.05 3.61 2.68 1.68 .64
D16S423 2` 2.89 2.77 2.17 1.39 .52
D16S3030 2` 2.99 2.85 2.22 1.41 .52
programs of the LINKAGE package version 5.1 (La-
throp et al. 1985) in the FASTLINK implementation
(Cottingham et al. 1993). A variable number of equi-
frequent alleles were used for LOD score calculations
according to the actual heterozygosity of the marker
within the white population. Marker order and distances
were obtained from the Ge´ne´thon map (Dib et al. 1996).
A fully penetrant autosomal recessive disease allele with
a frequency of .001 was assumed for linkage analysis.
The phenocopy rate was set at 0.
Results
We first typed a set of 181 microsatellite markers cov-
ering the 22 autosomes at an average distance of ∼20
cM. Because no suggestive evidence of linkage was found
with the initial screen, we typed a second set of 123
markers in order to reduce the intermarker distance to
∼10 cM. We observed a maximum LOD score of 1.74
at recombination fraction (v) .2 with marker D16S521
on chromosome 16p13. Additional markers were typed
to obtain a detailed genotypic map of the region in our
family. Two-point LOD scores and haplotypes are
shown in table 1 and figure 1, respectively.
The maximum LOD score of 4.48 was observed for
D16S3027 at . Furthermore, no obligate recom-v = 0
binants were observed for D16S3082 and D16S3084
(maximum LOD scores of 1.81 and 2.94, respectively,
at ). Four-point LOD scores of the regions peakedv = 0
at 4.69 (data not shown). Key recombinations were ob-
served in individual III-9 for D16S3024 and in individ-
ual III-12 (age 42 years) for D16S423, which allowed
the localization of the critical region to a 3.4-cM interval
of chromosome 16p13 between markers D16S3024 and
D16S423 (fig. 2).
Discussion
The idiopathic epilepsies are a very heterogeneous group
of neurologic disorders: among them are very common
disorders with a complex mode of inheritance and rare
syndromes inherited as Mendelian traits. Although very
little is known about the genetic factors implicated in
genetically complex idiopathic epilepsies, substantial
progress has been made in the rare Mendelian forms of
epilepsy. Mutations in genes encoding potassium chan-
nels (Biervert et al. 1998; Charlier et al. 1998; Singh et
al. 1998), the neuronal acetylcholine receptor a4 subunit
(Steinlein et al. 1995), and the sodium channel b1 sub-
unit (Wallace et al. 1998) have been, respectively, as-
sociated with familial benign neonatal convulsions
(BFNC [MIM 121200, 121201]), autosomal dominant
nocturnal frontal lobe epilepsy (MIM 600513), and a
syndrome characterized by generalized epilepsy and feb-
rile seizures (GEFS1) (MIM 604236).
Furthermore, autosomal loci responsible for benign
familial infantile convulsions (MIM 601764), benign
adult familial myoclonic epilepsy (MIM 601068), and
several Mendelian subsets of genetically complex epi-
lepsies such as childhood absence epilepsy (MIM
600131), juvenile myoclonic epilepsy (MIM 254770),
and partial epilepsy (MIM 604364) have been identified
on chromosomes 8q24, 6p21.2-p11, 10q22-q24, and
22q11-q12 by means of linkage analysis (Liu et al.
1995; Ottman et al. 1995; Guipponi et al. 1997; Fong
et al. 1998; Mikami et al. 1999; Plaster et al. 1999;
Xiong et al. 1999).
Although an increasing number of Mendelian idio-
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pathic epilepsies have been described and their under-
lying genes localized or cloned, their mode of inheri-
tance is autosomal dominant. We report here the
mapping of a locus predisposing to a familial myoclonic
epilepsy of infancy to chromosome 16p13.
To the best of our knowledge, this is the first example
of an idiopathic epilepsy that is inherited as autosomal
recessive trait. It is possible that recessive alleles causing
idiopathic epilepsy are rare. Alternatively, their fre-
quency may be underestimated because of difficulty in
mapping recessive traits in clinically and genetically het-
erogeneous disorders.
In the family described here, we identified two dif-
ferent haplotypes segregating with the disease, which
suggests that two different mutations might likely be
present and therefore that the affected family members
should be compound heterozygotes. This finding is con-
sistent with available data indicating that founders of
generation I are not consanguineous. In this hypothesis,
at least two mutant alleles should be present within the
Italian population, and hence this gene could play a
significant role. We cannot, however, exclude that a sin-
gle mutation, arisen from a common ancient founder,
is segregating in the family we describe here and that
different haplotypes have been originated by ancestral
crossovers that occurred close to the disease gene.
The myoclonic epilepsy segregating in the reported
kindred is not identifiable with any epileptic syndrome
described in ICE. It does, however, resemble SIME in
several features, such as constant presence of GTCS,
high frequency of febrile convulsions, long-lasting and
frequently provoked myoclonic seizures, and persistence
of clinical manifestations in adult life (Guerrini and
Dravet 1997), and it shares with BIME the normal psy-
chomotor development, the absence of neurologic def-
icit, and the good response to therapy (Vigevano et al.
1997). Intermediate forms between BIME and SIME
have already been described, and the hypothesis that
myoclonic epilepsy of infancy might represent a clinical
continuum with variable expression and severity has
been postulated (Lombroso 1990). By eventually iso-
lating the mutant gene, we could verify whether the
myoclonic epilepsy segregating in the reported kindred
represents a novel clinical entity or a specific expression
of a broader clinical picture.
We have mapped a gene for a familial idiopathic my-
oclonic epilepsy of infancy within a 3.4-cM region of
chromosome 16p13. Within this region, three genes po-
tentially involved in epileptogenesis have been mapped:
the voltage-dependent chloride channel 7 gene
(CLCN7), the synaptogyrin III gene (SYNGR3), and the
solute carrier family 9 isoform 3 regulatory factor 2
gene (SLC9A3R2).
CLCN7 is broadly expressed in different tissues and,
together with CLCN6, represents a specific branch
within the chloride-channel gene family (Brandt and
Jentsch 1995). Although very little is known about
CLCN7-specific functions, other members of the chlo-
ride-channel gene family have been implicated in re-
polarizing the cell membrane when expressed in Xen-
opus oocytes (Pusch et al. 1995). Because in BFNC
(MIM 121200, 121201) the moderate reduction of K1
repolarizing current has been demonstrated to be epi-
leptogenic (Schroeder et al. 1998), CLCN7 may rep-
resent an appealing candidate.
SYNGR3 encodes a synaptic vesicle membrane pro-
tein (Kedra et al. 1998). To date, synaptogyrins have
not been implicated in the etiology of epilepsy; however,
knockout mice of synapsin I and II (which are parts of
synaptic vesicle membranes) show spontaneous seizures
in the absence of any detectable structural brain ab-
normalities (Rosahl et al. 1995).
SLC9A3R2 was implicated in the regulation of the
sodium/hydrogen-exchanger isoform 3 (Brant et al.
1995; Yun et al. 1997). Because a mutation in the so-
dium/hydrogen-exchanger isoform 1 (SLC9A1) was
found to cause generalized seizures in the slow-wave
epilepsy mouse (Cox et al. 1997), the abnormal activity
of the related isoform 3 caused by altered regulation
might also be epileptogenic.
Our work discloses important new information re-
garding the potential mode of transmission of my-
oclonic epilepsies with pediatric onset and provides ev-
idence for a new locus implicated in idiopathic epilepsy
on chromosome 16p. Identification of genes involved in
the myoclonic epilepsies of infancy could provide a
more precise diagnosis of the various syndromes and
improve genetic counseling to patients and families. In
the future, new therapies may be developed to treat
myoclonic epilepsies resistant to currently available
drugs.
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